These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16365852)

  • 21. Treatment of recurrent or metastatic renal cell carcinoma.
    Shah RN; Ahmad T; Eisen TG
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1069-80. PubMed ID: 15606334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
    Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
    Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study on the effects of chemotherapy as treatment of renal cell carcinoma].
    Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):43-9. PubMed ID: 3379331
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunochemotherapy of metastatic renal cell carcinoma: report of 28 cases.
    Wang HJ; Chen HX; Li HZ
    Chin Med J (Engl); 2005 Jan; 118(2):172-3. PubMed ID: 15667805
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeted therapy of renal cell cancer.
    Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
    Curr Opin Investig Drugs; 2008 Jun; 9(6):570-5. PubMed ID: 18516756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma.
    Chapman AE; Goldstein LJ
    Semin Oncol; 1995 Feb; 22(1):17-28. PubMed ID: 7855615
    [No Abstract]   [Full Text] [Related]  

  • 27. Genitourinary malignancies.
    Smith MR; Kantoff P
    Cancer Chemother Biol Response Modif; 1999; 18():394-417. PubMed ID: 10800495
    [No Abstract]   [Full Text] [Related]  

  • 28. Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8.
    Karakiewicz P; Perrotte P; Trinh QD; Patard JJ
    Eur Urol; 2007 Jun; 51(6):1478-80. PubMed ID: 17275988
    [No Abstract]   [Full Text] [Related]  

  • 29. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Harshman LC; Srinivas S
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extension of survival by resection of asynchronous renal cell carcinoma metastases to mediastinal lymph nodes.
    Whitson BA; Groth SS; Andrade RS; Garrett L; Dudek AZ; Jessurun J; Maddaus MA
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1022-8. PubMed ID: 18455579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma.
    Amato RJ; Morgan M; Rawat A
    Cancer; 2006 Apr; 106(7):1498-506. PubMed ID: 16475152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting cancer-control outcomes in patients with renal cell carcinoma.
    Karakiewicz PI; Hutterer GC
    Curr Opin Urol; 2007 Sep; 17(5):295-302. PubMed ID: 17762620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
    Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
    J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage paclitaxel chemotherapy for metastatic collecting duct carcinoma of the kidney.
    Bagrodia A; Gold R; Handorf C; Liman A; Derweesh IH
    Can J Urol; 2008 Dec; 15(6):4425-7. PubMed ID: 19046497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presurgical therapy in metastatic renal cell carcinoma.
    Jonasch E
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):73-8. PubMed ID: 17187521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current treatment of renal cell carcinoma.
    De Mulder PH; van Herpen CM; Mulders PA
    Ann Oncol; 2004; 15 Suppl 4():iv319-28. PubMed ID: 15477330
    [No Abstract]   [Full Text] [Related]  

  • 38. Gastric metastasis from renal cancer six years after nephrectomy.
    Cruz A; Ramírez LM; Sánchez E; Ruiz M; Moreno I; López J; Sánchez F; De-Luna MM; Muntané J; Báez F; Padillo FJ
    Rev Esp Enferm Dig; 2011 Dec; 103(12):660-1. PubMed ID: 22217356
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy and prognostic factors.
    Fumagalli LA; Brivio F
    J Clin Oncol; 2006 Sep; 24(25):4218-9; author reply 4219-20. PubMed ID: 16943541
    [No Abstract]   [Full Text] [Related]  

  • 40. [Squamous cell carcinoma of the renal pelvis. Therapeutic options for a rare entity].
    Kazarians B; Kausch I; Doehn C; Jocham D
    Aktuelle Urol; 2008 Nov; 39(6):456-8. PubMed ID: 18979401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.